Clinical Trials Directory

Trials / Completed

CompletedNCT02369237

Non-invasive Determination of Anemia in Children With Renal Failure

A Non-invasive Device to Determine Iron Deficiency Anemia in Children of Different Age Groups With Renal Failure

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Center for Studies of Sensory Impairment, Aging and Metabolism · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Anemia and inflammation are very common in patients with renal diseases. The most common procedure to detect anemia is to determine blood hemoglobin concentrations. The Haemospect® is a portable device for non-invasive hemoglobin determination that works with a sensor that is applicable in infants and adults alike. The objective of this trial is to collect spectra with the non-invasive Haemospect® device in children of different age groups with renal failure and different hemoglobin concentrations. In parallel, corresponding hemoglobin values shall be obtained invasively to form the basis for the development of an algorithm for the device. To determine inflammation, the frequencies of vasomotion and oxygenation of the tissue are measured non-invasively with the Haemospect®. Various blood parameters for iron and inflammation will also be determined, such as ferritin, hepcidin, transferrin, serum iron, white blood cell count and CRP.

Conditions

Timeline

Start date
2012-04-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2015-02-23
Last updated
2015-02-23

Source: ClinicalTrials.gov record NCT02369237. Inclusion in this directory is not an endorsement.